Literature DB >> 26908951

Aortic stenosis and transthyretin cardiac amyloidosis: the chicken or the egg?

Arnault Galat1,2,3,4,5, Aziz Guellich1,2,3,4,5, Diane Bodez1,2,3,4,5, Michel Slama6, Marina Dijos7, David Messika Zeitoun8, Olivier Milleron8, David Attias9, Jean-Luc Dubois-Randé1,2,3,4,5, Dania Mohty10, Etienne Audureau1,2,4,5,11,12, Emmanuel Teiger1,2,3,4,5, Jean Rosso1,2,13, Jean-Luc Monin1,2,3,4,5, Thibaud Damy14,2,3,4,5.   

Abstract

BACKGROUND: Aortic stenosis (AS) and transthyretin cardiac amyloidosis (TTR-CA) are both frequent in elderly. The combination of these two diseases has never been investigated. AIMS: To describe patients with concomitant AS and TTR-CA.
METHODS: Six cardiologic French centres identified retrospectively cases of patients with severe or moderate AS associated with TTR-CA hospitalized during the last 6 years.
RESULTS: Sixteen patients were included. Mean ± SD age was 79 ± 6 years, 81% were men. Sixty per cent were NYHA III-IV, 31% had carpal tunnel syndrome, and 56% had atrial fibrillation. Median (Q1;Q4) NT-proBNP was 4382 (2425;4730) pg/mL and 91% had elevated cardiac troponin level. Eighty-eight per cent had severe AS (n = 14/16), of whom 86% (n = 12) had low-gradient AS. Mean ± SD interventricular septum thickness was 18 ± 4 mm. Mean left ventricular ejection fraction and global LS were 50 ± 13% and -7 ± 4%, respectively. Diagnosis of TTR-CA was histologically proven in 38%, and was based on strong cardiac uptake of the tracer at biphosphonate scintigraphy in the rest. Eighty-one per cent had wild-type TTR-CA (n = 13), one had mutated Val122I and 19% did not had genetic test (n = 3). Valve replacement was surgical in 63% and via transcatheter in 13%. Median follow-up in survivors was 33 (16;65) months. Mortality was of 44% (n = 7) during the whole follow-up period.
CONCLUSIONS: Combination of AS and TTR-CA may occur in elderly patients particularly those with a low-flow low-gradient AS pattern and carries bad prognosis. Diagnosis of TTR-CA in AS is relevant to discuss specific treatment and management. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author 2016. For permissions please email: journals.permissions@oup.com.

Entities:  

Keywords:  Aortic stenosis; Cardiac amyloidosis; Low-flow low-gradient; Transthyretin

Mesh:

Substances:

Year:  2016        PMID: 26908951     DOI: 10.1093/eurheartj/ehw033

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  31 in total

1.  ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2-evidence base and standardized methods of imaging.

Authors:  Sharmila Dorbala; Yukio Ando; Sabahat Bokhari; Angela Dispenzieri; Rodney H Falk; Victor A Ferrari; Marianna Fontana; Olivier Gheysens; Julian D Gillmore; Andor W J M Glaudemans; Mazen A Hanna; Bouke P C Hazenberg; Arnt V Kristen; Raymond Y Kwong; Mathew S Maurer; Giampaolo Merlini; Edward J Miller; James C Moon; Venkatesh L Murthy; C Cristina Quarta; Claudio Rapezzi; Frederick L Ruberg; Sanjiv J Shah; Riemer H J A Slart; Hein J Verberne; Jamieson M Bourque
Journal:  J Nucl Cardiol       Date:  2019-12       Impact factor: 5.952

2.  Transthyretin cardiac amyloid and aortic stenosis in the elderly, the role of nuclear imaging.

Authors:  Elisa Merli; Eleonora Del Giudice; Athanassios Antonopoulos; Gianadrea Amadei; Elisabetta Varani
Journal:  Int J Cardiovasc Imaging       Date:  2017-02-02       Impact factor: 2.357

3.  Apical sparing pattern of left ventricular myocardial 99mTc-HMDP uptake in patients with transthyretin cardiac amyloidosis.

Authors:  Axel Van Der Gucht; Anne-Ségolène Cottereau; Mukedaisi Abulizi; Aziz Guellich; Paul Blanc-Durand; Jean-Marc Israel; Arnault Galat; Violaine Plante-Bordeneuve; Jean-Luc Dubois-Randé; Diane Bodez; Jean Rosso; Thibaud Damy; Emmanuel Itti
Journal:  J Nucl Cardiol       Date:  2017-04-26       Impact factor: 5.952

4.  Absence of electrocardiographic left ventricular hypertrophy is associated with increased mortality after transcatheter aortic valve replacement.

Authors:  Polydoros N Kampaktsis; Ajayram V Ullal; Rajesh V Swaminathan; Robert M Minutello; Luke Kim; Geoffrey S Bergman; Dmitriy N Feldman; Harsimran Singh; Shing Chiu Wong; Peter M Okin
Journal:  Clin Cardiol       Date:  2018-08-21       Impact factor: 2.882

5.  Diagnostic accuracy of bone scintigraphy in the assessment of cardiac transthyretin-related amyloidosis: a bivariate meta-analysis.

Authors:  Giorgio Treglia; Andor W J M Glaudemans; Francesco Bertagna; Bouke P C Hazenberg; Paola A Erba; Raffaele Giubbini; Luca Ceriani; John O Prior; Luca Giovanella; Riemer H J A Slart
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-04-23       Impact factor: 9.236

Review 6.  Addressing Common Questions Encountered in the Diagnosis and Management of Cardiac Amyloidosis.

Authors:  Mathew S Maurer; Perry Elliott; Raymond Comenzo; Marc Semigran; Claudio Rapezzi
Journal:  Circulation       Date:  2017-04-04       Impact factor: 29.690

7.  Amyloid Cardiopathy and Aortic Stenosis.

Authors:  Leonida Gherasim
Journal:  Maedica (Bucur)       Date:  2021-09

Review 8.  Cardiac Amyloidosis.

Authors:  Morie A Gertz
Journal:  Heart Fail Clin       Date:  2022-07       Impact factor: 2.828

9.  Cardiac amyloidosis is prevalent in older patients with aortic stenosis and carries worse prognosis.

Authors:  João L Cavalcante; Shasank Rijal; Islam Abdelkarim; Andrew D Althouse; Michael S Sharbaugh; Yaron Fridman; Prem Soman; Daniel E Forman; John T Schindler; Thomas G Gleason; Joon S Lee; Erik B Schelbert
Journal:  J Cardiovasc Magn Reson       Date:  2017-12-07       Impact factor: 5.364

10.  Prevalence and prognostic impact of apical sparing contractility pattern in patients with aortic stenosis referred for transcatheter aortic valve implantation.

Authors:  Vera V Ferreira; Sílvia A Rosa; Tiago Pereira-da-Silva; Inês Rodrigues; António V Gonçalves; Tiago Mendonça; Alexandra Castelo; Luísa M Branco; Ana Galrinho; António Fiarresga; Ruben Ramos; Lino Patrício; Duarte Cacela; Rui C Ferreira
Journal:  Am J Cardiovasc Dis       Date:  2021-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.